Max Care will market and sell Equashield’s closed system transfer device for the safe compounding of hazardous drugs in Saudi Arabia, as well as the wider Middle East and North Africa (MENA) region.

Max Care Medical president and founder Ibrahim Al Bawardi said: “Having been cleared by the Saudi Food and Drug Authority (SFDA), and with registrations recently finalized, there is already market awareness and opportunity of Equashield’s products in the region.

Max Care Medical MENA executive director Dr Samer Salha said: “Hazardous drug risk awareness has grown in Saudi Arabia. Pharmacists are reading USP 800, and with a majority of our pharmacy and nursing professionals receiving their higher education in Western countries, we are committed to meeting the most stringent safety standards.

“Further, we are moving into an era of automation. Equashield is already a proven leader in safety with the EQUASHIELD CSTD. The Equashield Pro compounding robot will bring us to the future of safe and efficient robotic hazardous drug compounding.”

Max Care will showcase Equashield at two major upcoming regional events: The 5th Annual GCC Pharmacy Congress taking place in Dubai (October 11-13) at Booth 6, as well as the 4th IVPN Symposium(October 16-17), organized by the Cleveland Clinic Abu Dhabi.

Equashield marketing director Ronak Kadakia said: “Max Care Medical is an ideal partner for us. Saudi Arabia has a high level of awareness of hazardous drug hazards, and Max Care is working to educate surrounding MENA markets on the importance of adopting a high level of safe handling standards in accordance with USP 800.

“We have already seen growth in the Saudi market, with one of the country’s largest hospitals adopting Equashield this year to maintain its accreditation with ASHP standards. This is a trend we expect to continue with other institutions.”

Equashield is a leading provider of manual and automated solutions for the compounding and administration of hazardous drugs.

Equashield’s product suite includes EQUASHIELD II, its flagship Closed System Transfer Device (CSTD), and EQUASHIELD® Pro, the first ever closed system-enabled multi-station hazardous drug compounder.

Source: Company Press Release